Moshe Alafi - Net Worth and Insider Trading
Moshe Alafi Net Worth
The estimated net worth of Moshe Alafi is at least $349 Million dollars as of 2024-11-13. Moshe Alafi is the 10% Owner of Intra-Cellular Therapies Inc and owns about 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $349 Million. Details can be seen in Moshe Alafi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Moshe Alafi has not made any transactions after 2017-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Moshe Alafi
Moshe Alafi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Moshe Alafi owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of Moshe Alafi’s form 4 insider trades.
Insider Ownership Summary of Moshe Alafi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2017-10-02 | 10 percent owner |
| STXS | Stereotaxis Inc | 2004-08-11 | 10 percent owner |
Moshe Alafi Latest Holdings Summary
Moshe Alafi currently owns a total of 1 stock. Moshe Alafi owns 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) as of October 2, 2017, with a value of $349 Million.
Latest Holdings of Moshe Alafi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2017-10-02 | 3,953,270 | 88.22 | 348,757,479 |
Holding Weightings of Moshe Alafi
Moshe Alafi Form 4 Trading Tracker
According to the SEC Form 4 filings, Moshe Alafi has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the acquisition of 258,065 shares on October 2, 2017, which cost Moshe Alafi around $4 Million.
Insider Trading History of Moshe Alafi
- 1
Moshe Alafi Trading Performance
GuruFocus tracks the stock performance after each of Moshe Alafi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Moshe Alafi is -7.52%. GuruFocus also compares Moshe Alafi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Moshe Alafi within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Moshe Alafi's insider trading performs compared to the benchmark.
Performance of Moshe Alafi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.65 | | | | | |
| Relative Return to S&P 500(%) | -0.92 | | | | | |
Moshe Alafi Ownership Network
Ownership Network List of Moshe Alafi
Ownership Network Relation of Moshe Alafi
Moshe Alafi Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Moshe Alafi is the 10 percent owner of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , EVP & Chief Commercial Officer Mark Neumann , and Chief Medical Officer Suresh K. Durgam .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Moshe Alafi made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 156,651 shares made by Mark Neumann , and a net sale of 105,827 shares made by Suresh K. Durgam .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Moshe Alafi Mailing Address
Above is the net worth, insider trading, and ownership report for Moshe Alafi. You might contact Moshe Alafi via mailing address: 1311 Orleans Drive, Sunnyvale Ca 94089.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
